Titan Medical Inc. Retains Brooks Communications as Investor Relations Consultant
January 03 2014 - 4:29PM
Marketwired
Titan Medical Inc. Retains Brooks Communications as Investor
Relations Consultant
TORONTO, ONTARIO--(Marketwired - Jan 3, 2014) - Titan Medical
Inc. ("Titan" or the "Company") (TSX-VENTURE:TMD)(OTCQX:TITXF)
announced today that it has retained Brooks Communications to
provide strategic investor relations and financial communications
services for 2014.
Brooks Communications is a Canadian company headquartered in
Toronto, Canada. Over the last fifteen years, Brooks Communications
has provided strategic communications services to Canadian and U.S.
based public companies across a diverse range of sectors and
non-profit organizations. The principal of Brooks Communications is
Beverly Brooks.
The term of the contract with Brooks Communications commenced
January 1, 2014 and will expire December 31, 2014. The contract may
be terminated earlier upon 30 days written notice by either party.
The services to be provided by Brooks Communications include the
development and implementation of an investor relations strategy,
enhancements to Titan's website and investor presentation
materials, ongoing communications with current and prospective
investors, assistance with Titan's next annual meeting of
shareholders as well as timely presentations to current and
prospective investors. Brooks Communications will be paid fees of
$7,000 per month for its services during the term of the
contract.
About Brooks Communications
Brooks Communications was founded by Beverly Brooks as a
communications consulting company, which offers investor, public,
media, stakeholder and government relations strategies. Beverly
Brooks is an investor relations expert and economist who has
advised federal government Ministers and senior executives across
Canada on investor, government, stakeholder, media and public
relations strategies. She has developed investor relations
strategies, managed policy, regulatory and financial issues,
conducted outreach exercises to various stakeholders and arranged
major events for clients in a variety of sectors including
biotechnology, mining, energy, health care and
telecommunications.
About Titan Medical Inc.
Titan Medical Inc. is a Canadian public company
(TSX-VENTURE:TMD) (OTCQX:TITXF) focused on the design and
development of a robotic surgical system for application in
minimally invasive surgery ("MIS"). The Company's robotic surgical
system, currently under development, comprises a surgeon-controlled
robotic platform that includes a 3D vision system and interactive
instruments for performing MIS procedures, and a surgeon
workstation that provides the surgeon with an interface to the
robotic platform for controlling the interactive instruments and
providing a 3D endoscopic view of inside a patient's body during
MIS procedures. The robotic surgical system is being designed to
expand robotic surgery into areas of surgical specialties and
simple and complex procedures that are currently under-serviced,
and to allow surgeons to perform procedures within small to medium
size surgical spaces such as general surgery and cholecystectomy.
For more information, visit the Company's website at
www.titanmedicalinc.com.
Forward-Looking Statements
This news release contains "forward-looking statements" which
reflect the current expectations of management of the Company's
future growth, results of operations, performance and business
prospects and opportunities. Wherever possible, words such as
"may", "would", "could", "will", "anticipate", "believe", "plan",
"expect", "intend", "estimate", "potential for" and similar
expressions have been used to identify these forward-looking
statements. These statements reflect management's current beliefs
with respect to future events and are based on information
currently available to management. Forward-looking statements
involve significant risks, uncertainties and assumptions. Many
factors could cause the Company's actual results, performance or
achievements to be materially different from any future results,
performance or achievements that may be expressed or implied by
such forward-looking statements, including, without limitation,
those listed in the "Risk Factors" section of the Company's Annual
Information Form dated April 10, 2013 (which may be viewed at
www.sedar.com). Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward looking
statements prove incorrect, actual results, performance or
achievements may vary materially from those expressed or implied by
the forward-looking statements contained in this news release.
These factors should be considered carefully and prospective
investors should not place undue reliance on the forward-looking
statements. Although the forward-looking statements contained in
the news release are based upon what management currently believes
to be reasonable assumptions, the Company cannot assure prospective
investors that actual results, performance or achievements will be
consistent with these forward-looking statements.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Titan Medical Inc.John HargroveInterim Chief Executive
Officer(416) 548-7522 (ext.
151)john.hargrove@titanmedicalinc.comwww.titanmedicalinc.comBeverly
BrooksInvestor Relations(416)
482-8889brooks.communications@rogers.com
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From Apr 2024 to May 2024
Titan Medical (NASDAQ:TMDI)
Historical Stock Chart
From May 2023 to May 2024